Seropositive myasthenia gravis: a nationwide epidemiologic study - PubMed (original) (raw)

Seropositive myasthenia gravis: a nationwide epidemiologic study

Anne Taraldsen Heldal et al. Neurology. 2009.

No abstract available

PubMed Disclaimer

Similar articles

• Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
  Somnier FE. Somnier FE. Neurology. 2005 Sep 27;65(6):928-30. doi: 10.1212/01.wnl.0000176067.32186.a3. Neurology. 2005. PMID: 16186537
• Adult onset acquired myasthenia gravis in three Great Dane littermates.
  Kent M, Glass EN, Acierno M, Shelton GD. Kent M, et al. J Small Anim Pract. 2008 Dec;49(12):647-50. doi: 10.1111/j.1748-5827.2008.00627.x. Epub 2008 Aug 5. J Small Anim Pract. 2008. PMID: 18684140
• Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
  Popperud TH, Boldingh MI, Brunborg C, Faiz KW, Heldal AT, Maniaol AH, Müller KI, Rasmussen M, Øymar K, Kerty E. Popperud TH, et al. Eur J Paediatr Neurol. 2017 Mar;21(2):312-317. doi: 10.1016/j.ejpn.2016.09.001. Epub 2016 Sep 10. Eur J Paediatr Neurol. 2017. PMID: 27666466
• Lifetime course of myasthenia gravis.
  Grob D, Brunner N, Namba T, Pagala M. Grob D, et al. Muscle Nerve. 2008 Feb;37(2):141-9. doi: 10.1002/mus.20950. Muscle Nerve. 2008. PMID: 18059039 Review.
• 'Seronegative' myasthenia gravis is no longer seronegative.
  Lindstrom J. Lindstrom J. Brain. 2008 Jul;131(Pt 7):1684-5. doi: 10.1093/brain/awn131. Epub 2008 Jun 16. Brain. 2008. PMID: 18558616 Review. No abstract available.

Cited by

• Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance.
  Murai H, Suzuki S, Hasebe M, Fukamizu Y, Rodrigues E, Utsugisawa K. Murai H, et al. Ther Adv Neurol Disord. 2021 Mar 16;14:17562864211001995. doi: 10.1177/17562864211001995. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33796147 Free PMC article.
• Protein Arginine Methyltransferases in Neuromuscular Function and Diseases.
  Lee J, An S, Lee SJ, Kang JS. Lee J, et al. Cells. 2022 Jan 21;11(3):364. doi: 10.3390/cells11030364. Cells. 2022. PMID: 35159176 Free PMC article. Review.
• Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.
  Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, Shohaimi S, Mohammadi M. Salari N, et al. J Transl Med. 2021 Dec 20;19(1):516. doi: 10.1186/s12967-021-03185-7. J Transl Med. 2021. PMID: 34930325 Free PMC article.
• Clinical features and outcomes of patients with myasthenia gravis.
  Alanazy MH. Alanazy MH. Neurosciences (Riyadh). 2019 Jul;24(3):176-184. doi: 10.17712/nsj.2019.3.20190011. Neurosciences (Riyadh). 2019. PMID: 31380816 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information